Primary |
Type 2 Diabetes Mellitus |
74.7% |
Hypertension |
5.5% |
Diabetes Mellitus |
4.0% |
Constipation |
2.0% |
Cardiac Failure Congestive |
1.9% |
Diabetes Mellitus Non-insulin-dependent |
1.7% |
Benign Prostatic Hyperplasia |
1.6% |
Hypertonic Bladder |
1.3% |
Diabetic Retinopathy |
1.2% |
Dyslipidaemia |
1.0% |
Depression |
0.7% |
Gastrooesophageal Reflux Disease |
0.7% |
Seasonal Allergy |
0.7% |
Atrial Fibrillation |
0.6% |
Eczema |
0.4% |
Ocular Hypertension |
0.4% |
Prophylaxis |
0.4% |
Tuberculosis |
0.4% |
Anaemia |
0.3% |
Angina Pectoris |
0.3% |
|
Hypoglycaemia |
18.8% |
Hepatic Function Abnormal |
10.2% |
Viith Nerve Paralysis |
10.2% |
Pancreatitis Acute |
9.4% |
Angioedema |
7.8% |
Renal Failure Acute |
7.0% |
Pancreatitis |
4.7% |
Chest Pain |
3.1% |
Cholecystitis Acute |
3.1% |
Diarrhoea |
3.1% |
Cerebrovascular Accident |
2.3% |
Gastritis |
2.3% |
Hepatic Neoplasm Malignant |
2.3% |
Polymyalgia Rheumatica |
2.3% |
Rash |
2.3% |
Stillbirth |
2.3% |
Thrombocytopenia |
2.3% |
Urinary Tract Infection |
2.3% |
Vomiting |
2.3% |
Back Pain |
1.6% |
|
Secondary |
Type 2 Diabetes Mellitus |
58.8% |
Product Used For Unknown Indication |
25.8% |
Drug Use For Unknown Indication |
6.0% |
Diabetes Mellitus |
3.3% |
Hypertension |
1.4% |
Analgesic Therapy |
0.7% |
Angina Pectoris |
0.6% |
Type Ii Diabetes Mellitus |
0.5% |
Type 2 Diabetes Mellitus |
0.4% |
Aortic Aneurysm |
0.4% |
Gingivitis |
0.4% |
Cardiac Failure Chronic |
0.2% |
Pain |
0.2% |
Staphylococcal Infection |
0.2% |
Drug Use For Unknown Indication |
0.2% |
Atrial Fibrillation |
0.2% |
Cardiovascular Disorder |
0.2% |
Helicobacter Test Positive |
0.2% |
Renal Failure Chronic |
0.2% |
Arthritis Infective |
0.1% |
|
Renal Failure Acute |
21.6% |
Pneumonia |
13.0% |
Syncope |
13.0% |
Vomiting |
11.1% |
Hypoglycaemia |
5.6% |
Gastric Ulcer |
4.3% |
Hyperkalaemia |
3.7% |
Hypotension |
3.1% |
Aortic Aneurysm |
2.5% |
Pain |
2.5% |
Pancreatitis |
2.5% |
Pulmonary Oedema |
2.5% |
Bladder Cancer |
1.9% |
Cardiac Failure Chronic |
1.9% |
Chest Pain |
1.9% |
Dyspnoea |
1.9% |
Gastrointestinal Haemorrhage |
1.9% |
Hyperhidrosis |
1.9% |
Nodal Arrhythmia |
1.9% |
Oedema Peripheral |
1.9% |
|
Concomitant |
Type 2 Diabetes Mellitus |
36.0% |
Product Used For Unknown Indication |
17.1% |
Diabetes Mellitus |
9.2% |
Hypertension |
6.9% |
Diffuse Large B-cell Lymphoma |
3.6% |
Renal Cell Carcinoma |
3.3% |
Blood Cholesterol |
2.8% |
Cardiac Failure Chronic |
2.8% |
Pain |
2.8% |
Acute Coronary Syndrome |
2.6% |
Hepatitis C |
1.9% |
Ischaemia |
1.7% |
Back Pain |
1.4% |
Atrial Fibrillation |
1.2% |
Chest Pain |
1.2% |
Depression |
1.2% |
Hypercholesterolaemia |
1.2% |
Prophylaxis |
1.2% |
Blood Glucose Increased |
0.9% |
Cardiac Failure |
0.9% |
|
Hypoglycaemia |
9.6% |
Renal Failure Acute |
9.6% |
Vomiting |
8.2% |
Bradycardia |
6.8% |
Pneumonia |
6.8% |
Shock |
6.8% |
Gastrooesophageal Reflux Disease |
5.5% |
Abdominal Pain Upper |
4.1% |
Asthenia |
4.1% |
Hyperkalaemia |
4.1% |
Pancreatitis Acute |
4.1% |
Renal Impairment |
4.1% |
Splenomegaly |
4.1% |
Urinary Tract Infection |
4.1% |
White Blood Cell Count Decreased |
4.1% |
Acute Myocardial Infarction |
2.7% |
Angina Pectoris |
2.7% |
Arterial Occlusive Disease |
2.7% |
Aspartate Aminotransferase Increased |
2.7% |
Atrioventricular Block Complete |
2.7% |
|
Interacting |
Type 2 Diabetes Mellitus |
100.0% |
|
|